Informed nondissent is a form of shared decision-making that reverses the usual expectation that parents must actively approve a clinician’s recommendation before care proceeds. Instead, the clinical team explains what it believes is medically appropriate, makes the reasoning transparent, and gives parents a clear opportunity to object. If parents understand the recommendation and do not dissent, the team may move forward while continuing to monitor whether their views remain consistent with the plan. The model is not designed to turn silence into consent. Its central premise is that parents should be informed, heard, and able to refuse or challenge the recommendation, while clinicians retain responsibility for offering professional judgment.

That distinction is particularly important in the NICU, where newborns may be unable to communicate and parents must make decisions under extreme emotional and cognitive strain. Critically ill infants can require mechanical ventilation, surgery, medications that support blood pressure, dialysis, or prolonged nutritional support. In some cases, clinicians conclude that the infant’s condition is unlikely to improve or that continued intervention may prolong suffering without achieving goals the family considers meaningful. The medical facts may be uncertain, but the ethical pressure is immediate. Parents are asked to interpret complex prognostic information while coping with fear, exhaustion, grief, and the possibility of losing their child.

Traditional shared decision-making generally emphasizes affirmative agreement. Clinicians describe the options, discuss benefits and burdens, and ask parents to select a path that reflects their values. This approach protects parental authority and can be essential when choices are closely balanced or when the consequences of an intervention are substantial. Yet affirmative decision-making can also place a heavy burden on parents who feel that they are personally causing a treatment to begin, continue, or stop. Some may repeatedly ask clinicians what they would do, hoping for guidance rather than a menu of options. Others may communicate indirectly because they are not ready to state openly that they want life-sustaining treatment withdrawn.

The authors describe informed nondissent as a way to respond to that communication without abandoning parental participation. A clinician might say that, based on the infant’s condition, the team recommends shifting from an escalation-focused plan to comfort-focused care. The clinician would then explain the medical reasoning, describe what the change would involve, and ask the parents whether they disagree or want more time, clarification, or another consultation. Parents would not be required to produce a formal declaration before their concerns could be addressed. At the same time, a lack of objection would not be treated as proof that they are unconcerned, emotionally prepared, or fully settled.

The technical and ethical work lies in distinguishing nondissent from passive acquiescence. Parents may remain silent because they are confused, intimidated, overwhelmed, or unable to process information. Language barriers, cultural differences, unequal power between families and medical teams, and previous negative experiences with healthcare can all affect how disagreement is expressed. A parent who nods may be acknowledging that they heard the recommendation rather than endorsing it. For that reason, informed nondissent requires clinicians to use plain language, check understanding, invite questions repeatedly, and make disagreement psychologically safe. It also requires attention to nonverbal cues and to changes in a family’s behavior, while avoiding the assumption that those cues have only one meaning.

Used carefully, the approach may reduce decisional conflict. Parents often experience distress when they believe they must choose between opposing medical options without sufficient expertise, or when different members of the clinical team appear to offer inconsistent recommendations. A clear professional recommendation can provide structure. It tells families how clinicians interpret the prognosis, what outcomes are considered realistically achievable, and why one plan may better fit the infant’s clinical situation and the family’s stated values. Informed nondissent preserves space for parental values while reducing the expectation that parents must independently determine the medically appropriate course.

The model may also help address moral distress among clinicians. Neonatal professionals can experience moral distress when they believe treatment is no longer beneficial but feel unable to recommend a change, or when they perceive that families are asking for interventions that impose significant burdens without a plausible path to the goals being pursued. Conversely, clinicians may feel distressed if they believe a family is moving toward limitation of treatment without fully understanding the prognosis. By making clinical recommendations explicit and inviting objection, informed nondissent can clarify professional responsibility while keeping the family’s perspective central. It does not eliminate disagreement, uncertainty, or grief, but it may make the decision process more coherent.

The paper nevertheless emphasizes that informed nondissent is not a shortcut around consent, and it must not become a mechanism for overriding parents. Parental authority includes the ability to disagree, request additional information, seek a second opinion, ask for more time, and express values that clinicians do not share. The approach is inappropriate when parents are actively objecting, when the decision is highly contested, when the medical recommendation is uncertain, or when parents lack a meaningful opportunity to understand and respond. Documentation should reflect what was explained, what questions were asked, how understanding was assessed, and whether parents expressed agreement, uncertainty, or dissent. Ethics consultation, palliative care involvement, interpreters, and repeated meetings may be necessary safeguards.

Informed nondissent is therefore best understood not as a replacement for shared decision-making but as a carefully bounded variation within it. Its success depends on the quality of communication before any recommendation is accepted: the accuracy of prognostic information, the clinician’s willingness to explain uncertainty, and the family’s confidence that objection will not jeopardize their relationship with the care team. In the NICU, where parents often communicate through tentative questions rather than definitive declarations, that distinction can be crucial. The authors’ message is both practical and cautionary: when clinicians believe a change in goals of care is appropriate, they should say so clearly, invite disagreement directly, and continue listening even after parents appear not to dissent. The goal is not to make decisions easier by making parents less involved, but to make difficult decisions more transparent, humane, and aligned with the values of the family and the needs of the infant.

Subject of Research: Informed nondissent as a shared decision-making approach for goals-of-care decisions in neonatal intensive care units.

Article Title: Informed nondissent: an underutilized tool for the NICU context

Article References: Wilson, S., Gregory, E., Kukora, S. et al. “Informed nondissent: an underutilized tool for the NICU context.” Journal of Perinatology (2026). https://doi.org/10.1038/s41372-026-02853-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41372-026-02853-0

Keywords: neonatal intensive care, informed nondissent, shared decision-making, goals of care, parental authority, neonatal ethics, moral distress, end-of-life care, clinician-family communication, critically ill newborns

A pregnancy is conventionally described as full term at approximately 40 weeks, while delivery before 37 weeks is considered preterm. Birth at 21 weeks occurs nearly four months before full term and is positioned at the extreme edge of viability. At this stage, the lungs are structurally immature, the brain is still undergoing rapid organization, the skin provides a fragile barrier against fluid and infection, and many organ systems cannot yet maintain the physiological stability required outside the uterus. Even with advanced intensive care, infants born this early face profound risks involving respiration, circulation, infection, nutrition, vision and neurological development.

The new report is significant because it treats these challenges as interconnected rather than isolated. Survival alone does not reveal the full consequences of extreme prematurity. A newborn may survive an intensive-care admission but later experience difficulties involving motor coordination, language, cognition, hearing, vision or behavioral regulation. Neurodevelopmental follow-up is therefore essential: it provides a longer view of how early injury, medical complications and the infant’s environment interact. Such assessments commonly examine domains including gross and fine motor skills, receptive and expressive language, problem-solving, social interaction and adaptive behavior, although the specific measures and findings must be interpreted in the context of the individual child.

Infants born at 21 weeks are exposed to a cascade of physiological stresses. Their lungs may lack sufficient surfactant, a substance that prevents the tiny air sacs from collapsing during breathing. Mechanical ventilation and supplemental oxygen can support gas exchange, but they may also contribute to inflammation and injury in developing lung tissue. The immature cardiovascular system can struggle to maintain blood pressure and adequate blood flow, while the fragile vessels of the developing brain are vulnerable to bleeding. A serious intraventricular hemorrhage, or bleeding into the brain’s ventricular spaces, can disrupt the tissues responsible for later movement and cognition. These risks make every decision in the neonatal intensive-care unit highly time-sensitive.

The brain at this gestational age is not simply a smaller version of a mature brain. It is in a phase of rapid growth, with neural connections forming, migrating and reorganizing at extraordinary speed. The transition from the protected intrauterine environment to intensive care can alter oxygen levels, blood flow, sensory stimulation and sleep patterns. Inflammation, infection and fluctuations in carbon dioxide or blood pressure may further affect the developing nervous system. At the same time, the brain retains substantial plasticity, meaning that developing neural networks can adapt and sometimes compensate after injury. Follow-up studies are designed to capture both vulnerability and resilience, rather than assuming that an early medical crisis determines a child’s entire future.

The case-series format is particularly useful for rare and complex clinical situations, but it also has important limitations. Unlike a randomized clinical trial, a case series does not compare patients with a control group and cannot establish that a particular treatment caused a particular outcome. The number of infants is generally small, and the children may differ substantially in birth weight, sex, medical complications, treatment decisions and family circumstances. Outcomes can also be influenced by the resources available in a hospital, the timing of specialized interventions and the therapies provided after discharge. For these reasons, the report should be read as detailed clinical evidence about a small group, not as a prediction for every infant born at 21 weeks.

The inclusion of neurodevelopmental follow-up nevertheless adds a crucial layer of information to debates about the so-called limit of viability. Decisions around births at the edge of viability involve physicians, nurses, parents, ethicists and, where possible, the values and preferences of the family. They must account for the likelihood of survival, the risk of severe impairment, the infant’s condition at birth and the capacity of the medical team. These decisions are not determined by gestational age alone. A difference of days can matter, but so can fetal growth, exposure to antenatal corticosteroids, the presence of infection, complications during delivery and the infant’s response to resuscitation.

For families, the most difficult uncertainty is that population statistics cannot precisely determine an individual child’s future. Some extremely premature infants experience severe complications, while others show unexpectedly strong developmental progress. Even when early assessments appear reassuring, development can change as children reach school age and face more complex demands involving attention, language, memory and social interaction. Conversely, early delays do not always predict permanent disability. This is why continuing surveillance by neonatologists, neurologists, developmental pediatricians, therapists, ophthalmologists and other specialists can be as important as the initial intensive-care treatment.

The report also highlights how the meaning of “successful” neonatal care is changing. Earlier generations of research often centered on mortality, but modern neonatal medicine increasingly evaluates survival without severe morbidity, quality of life and participation in everyday activities. Those outcomes are shaped not only by biology and hospital treatment but also by early intervention, family support, access to rehabilitation and social conditions. A child’s developmental trajectory cannot be separated entirely from the care available after leaving the hospital. The study’s emphasis on follow-up therefore reflects a broader movement in medicine toward measuring what patients are able to do and how they live, rather than simply whether they remain alive.

Cases at 21 weeks remain extraordinarily uncommon and medically complex, and the new findings should not be interpreted as evidence that viability has been universally redefined. Instead, the study contributes another carefully documented piece to a rapidly evolving scientific and ethical landscape. Its central message is that the boundaries of neonatal care cannot be evaluated through survival figures alone. Each case requires individualized assessment, transparent communication and long-term monitoring. As technology improves, the most consequential question will not only be whether an infant can be supported outside the womb, but whether that support can lead to meaningful development and a life in which the child can grow, learn and participate as fully as possible.

Subject of Research: Outcomes and neurodevelopment after birth at 21 weeks’ gestation

Article Title: Outcomes at 21 weeks’ gestation: a case series with neurodevelopmental follow-up

Article References: Dolma, K., Eyal, F., Shrestha, D. et al. Outcomes at 21 weeks’ gestation: a case series with neurodevelopmental follow-up. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02866-9

Image Credits: AI Generated

DOI: 10.1038/s41372-026-02866-9

Keywords: extreme prematurity, 21 weeks’ gestation, neonatal intensive care, limit of viability, neurodevelopment, preterm birth, infant outcomes, neonatal medicine